Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A versatile in vivo platform for reversible control of transgene expression in adult tissues

ABSTRACT: Temporal control of exogenous genes through artificial genetic circuits has advanced a range of biomedical interventions, including in vivo reprogramming. The doxycycline (Dox)-mediated Tet- ON system has been widely employed due to its highly reversible and tunable gene induction. Nonetheless, its effectiveness in vivo is limited by inherent resistance in some tissues. In the present study, mouse models were developed with the Tet-ON or complementary Tet-OFF system to thoroughly investigate the spatial and temporal control of transgene expression in adult tissues. The Tet-OFF system could induce gene expression in a broad spectrum of cell types, such as neuronal cells, cardiomyocytes, and skeletal muscle cells, in stark contrast with the Tet-ON system, which could only induce gene expression in particular tissues and cell types, mainly epithelial cells. Despite its broader reach, the Tet-OFF system exhibited slow inducibility and lacked tunability in the expression levels of transgenes. Capitalizing on the pharmacologic advantages of tetracycline (Tc), which has a shorter half-life in vivo and lower affinity for Tet repressor than Dox, we revisited its application. Remarkably, Tc enabled rapid, reversible, and graded control of transgene expression in the Tet-OFF system. Moreover, utilization of Tc mitigated the transcriptional perturbation associated with use of Dox. Our data suggest that the Tc-mediated Tet-OFF system not only enables more versatile control of transgene expression but may also offer a more biocompatible alternative, enhancing its suitability for applications such as tissue regeneration and organismal rejuvenation.

ORGANISM(S): Mus musculus

PROVIDER: GSE268589 | GEO | 2025/02/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

murine MYC-dependent lymphoma cells: Dox vs. NoDox treatment

2008-08-12 | GSE12394 | GEO

murine MYC-dependent lymphoma cells: Dox vs. NoDox treatment

Project description:miRNA expression profiling of murine MYC-dependent lymphoma cell lines harboring the MYC-transgene in a Tet-off system comparing control untreated lymphoma cells (high MYC expression state) with 18hours Dox treated lymphoma cells (low MYC expression state). Keywords: inducible expression system Two-condition experiment, Dox vs. NoDox treatment. Biological replicates: 26 distinct cell lines, 1 technical replicate. Four replicates per array.

2010-05-25 | E-GEOD-12394 | biostudies-arrayexpress

A versatile in vivo platform for reversible control of transgene expression in adult tissues

Project description:A versatile in vivo platform for reversible control of transgene expression in adult tissues

| PRJNA1117865 | ENA

Atrial and ventricular transcriptomic alterations in a cardiac mouse model of myotonic dystrophy expressing 960 CUG repeats

Project description:Purpose: The goal of this study was to characterize the atrial and ventricular transcriptomic changes in a cardiac mouse model of myotonic dystrophy. The mouse model utilizes a bitransgenic system for doxycycline (dox) inducible and cardiomyocyte specific expression of pathogenic RNA containing 960 CUG repeats. Bitransgenic animals (called CUG960 mice) homozygous for the TREDT960I transgene (containing 960 interrupted CTG repeats) and hemizygous for reverse transactivator (rtTA) transgene containing a cardiomyocyte-specific alpha myosin heavy chain promoter are given dox food for expression of CUG repeat RNA. Mice hemizygous for rtTA transgene (MHCrtTA) given dox food were used as controls. Methods:We performed RNA-seq for high-resolution analysis of transcriptomic alterations in atria and ventricles of CUG960 experimental and MHCrtTA control mice given dox chow since postnatal day 1 (PN1) for a period of 10 weeks. Results: We identified pathogenic CUG repeat RNA induced gene expression and alternative splicing changes in ion transport genes that are associated with inherited cardiac conduction diseases, including a subset of genes involved in calcium handling. Conclusions: We identified potential tissue-specific mechanisms contributing to the cardiac disease relevant phenotypes in an animal model of DM1.

2021-01-15 | GSE164825 | GEO

Transgenic overexpression of Tcfap2c/AP-2gamma results in liver steatosis

2011-07-26 | GSE28692 | GEO

Effect of doxycycline on the gut microbiome and neuroinflammation

Project description:Abstract: Many mouse models of neurological disease use the tetracycline transactivator (tTA) system to control transgene expression by oral treatment with the broad-spectrum antibiotic doxycycline. Antibiotic treatment used for transgene control might have undesirable systemic effects, including the potential to affect immune responses in the brain via changes in the gut microbiome. Recent work has shown that an antibiotic cocktail to perturb the gut microbiome can suppress microglial reactivity to brain amyloidosis in transgenic mouse models of Alzheimer's disease based on controlled overexpression of the amyloid precursor protein (APP). Here we assessed the impact of chronic low dose doxycycline on gut microbiome diversity and neuroimmune response to systemic LPS challenge in a tTA-regulated model of Alzheimer's amyloidosis. We show that doxycycline decreased microbiome diversity in both APP transgenic and wild-type mice and that these changes persisted long after drug withdrawal. Despite this change in microbiome composition, dox treatment had minimal effect on transcriptional signatures in the brain, both at baseline and following acute LPS challenge. Our findings suggest that central neuroinflammatory responses may be less affected by dox at doses needed for transgene control than by antibiotic cocktail at doses used for microbiome manipulation.

2024-01-10 | GSE236242 | GEO

Transgenic overexpression of Tcfap2c/AP-2gamma results in liver steatosis

Project description:We established a mouse model, in which transcription factor Tcfap2c can be activated in an inducible and reversible manner in somatic tissues, taking advantage of the tetracycline-dependent regulatory system. Induction of the transgene led to robust expression in all tissues (except brain and testis) and lead to rapid mortality within 3-7 days. In the liver, accumulation of microvesicular lipid droplets and breakdown of major hepatic metabolism pathways resulted in steatosis. Transgenic and control mice were treated with doxycycline (1mg/d i.p.) three times (0, 24 and 48h) and liver samples were collected after 52h. In addition, primary hepatocytes isolated from transgenic and control animals were cultured with doxycycline for 3 days (1µg/ml).

2011-07-25 | E-GEOD-28692 | biostudies-arrayexpress

Combining recombinase-mediated cassette exchange strategy with quantitative proteomic and phosphoproteomic analyses to inspect intracellular functions of the tumor supressor galectin-4 in colorectal cancer cells.

Project description:In order to systematically explore Galectin-4 function in CRC we established a CRC cell line where Gal4 expression can be regulated via doxycycline (dox)-inducible expression of a single copy wildtype LGALS4 transgene generated by recombinase-mediated cassette exchange (RMCE). Using this model and applying in depth proteomic and phosphoproteomic analyses we systematically screened for intracellular changes induced by Gal4 expression by.

2022-08-12 | PXD032902 | Pride

Genome-wide tongue epithelia transcriptomic profiles from K14-rtTA;TRE-FLBmi-1 (KrTB) and KrTB+Doxycycline (KrTB+DOX).

Project description:We developed a transgenic mouse model (truncated K14-rtTA; TRE/Bmi1, KrTB) containing a doxycycline- (dox) controlled, Tet-responsive element system to selectively overexpress Bmi1 only in the basal epithelial SCs of the tongue. Here, we used this model to assess Bmi1 actions in tongue epithelia. Genome-wide transcriptomics revealed increased levels of transcripts involved in the cellular response to hypoxia in Bmi1-overexpressing (KrTB+DOX) mice.

2024-08-16 | GSE241153 | GEO

Transcription profiling of mouse ES cells treated by varying levels of activated Smad2/3 over time in the presence of protein synthesis

Project description:The tet-on system was activated by treatment of the cells with doxycycline (Dox) in concentrations 1 microgram per milliliter. The Smad2/3 phosphorylation was inhibited by treatment of the cells with SB-431542. The TAG1 cells were treated with SB inhibitor and Dox activator and samples were analyzed by microarrays (affymetrix) at different time points during this treatment.

2009-01-01 | E-TABM-574 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data